Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > RE :TFSA

<< Previous

Bullboard Posts

Next >>

Post by Felix12345on Jan 04, 2022 3:04pm

271 Views

Post# 34282715

RE :TFSA

PUTTING $6000.00 worth of TH into a TFSA account is the worst ppossibe move anyone could make. .TFSA IS FOR +HIGRADE DIVIDEND STOCKS; IF TH GOES DOWN AND YOU SELL YOU LOSE THAT CONTRIBUTION ROOM FOR EVER.Stick to stocks that pay dividends for the last 5 years.Better yet buy ETF that mimic the S&P 500 ...

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?